PHERECYDES PHARMA
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
PHERECYDES PHARMA
Industry:
Biotechnology Health Care Medical Device
Founded:
2006-01-01
Address:
Romainville, Ile-de-France, France
Country:
France
Website Url:
http://www.pherecydes-pharma.com
Total Employee:
11+
Status:
Active
Contact:
+330148406535
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Euro Yoast WordPress SEO Plugin ReCAPTCHA Yoast SEO Premium Yoast Plugins
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Channel Medsystems
Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Grant - Pherecydes Pharma
Ace Capital Partners
Ace Capital Partners investment in Series B - Pherecydes Pharma
FaDièse
FaDièse investment in Series B - Pherecydes Pharma
Karista
Karista investment in Series B - Pherecydes Pharma
GO CAPITAL
GO CAPITAL investment in Series B - Pherecydes Pharma
Auriga Partners
Auriga Partners investment in Series B - Pherecydes Pharma
Omnes Capital
Omnes Capital investment in Series B - Pherecydes Pharma
Ace Capital Partners
Ace Capital Partners investment in Venture Round - Pherecydes Pharma
Auriga Partners
Auriga Partners investment in Venture Round - Pherecydes Pharma
Karista
Karista investment in Series A - Pherecydes Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-07 | Pherecydes Pharma Announces the Appointment of Thibaut du Fayet as Chief Operating Officer and Member of the Executive Board |
Official Site Inspections
http://www.pherecydes-pharma.com
- Host name: 104.21.11.222
- IP address: 104.21.11.222
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pherecydes Pharma"
Pherecydes Pharma - Crunchbase Company Profile
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The …See details»
Pherecydes Pharma SA
Explore Pherecydes Pharma SA with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 26 news, and 17 literature, Disease Domain:Infectious Diseases, Endocrinology …See details»
Pherecydes Pharma Company Profile 2024: Valuation, …
Pherecydes Pharma General Information Description. Pherecydes Pharma develops phage-based therapeutic solutions for the treatment of bacterial …See details»
ERYTECH and PHERECYDES announce merger and …
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics . ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a clinical-stage biopharmaceutical …See details»
Société Anonyme - investors.erytech.com
S.A. au capital de 3.412.029,80 € RCS LYON n°479 560 013 - APE : 7211Z SIRET : 479 560 013 00019 PHERECYDES PHARMA Société Anonyme incorporated under French law with a …See details»
Organization | Pherecydes Pharma
Organization Overview. First Clinical Trial. 2015 NCT02116010. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Pherecydes Pharma Active Ingredients. Drugs in …See details»
Pherecydes Pharma - LinkedIn
Pherecydes Pharma | 4,401 followers on LinkedIn. At the forefront of the fight against antibioresistant bacteria | Pherecydes Pharma develops antibacterial treatments based on the …See details»
Pherecydes Pharma - Funding, Financials, Valuation & Investors
Pherecydes Pharma Operator of an innovative biotechnologies company created to develop personalized phage therapy.See details»
Société PHERECYDES PHARMA : Chiffre d'affaires, statuts
Sep 19, 2023 PHERECYDES PHARMA à NANTES (44000) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS, SIREN ...See details»
Pherecydes Pharma Company Profile - Office Locations ... - Craft
Pherecydes Pharma has 5 employees at their 1 location and $16.46 m in total funding,. See insights on Pherecydes Pharma including office locations, competitors, revenue, financials, …See details»
Pherecydes Pharma - Products, Competitors, Financials, Employees ...
Pherecydes Pharma (EPA: ALPHE) is a biotechnology company that specializes in the research and development of anti-infective therapies based on the use of bacteriophages. It focuses on …See details»
Pherecydes Pharma announces a change in its governance …
For more information, www.pherecydes-pharma.com Contacts Pherecydes Pharma Guy-Charles Fanneau de La Horie Chairman of the Executive Board [email protected] …See details»
ERYTECH et PHERECYDES annoncent leur fusion pour former …
Jun 26, 2023 Lyon (France) et Cambridge (MA, US), 26 juin 2023 - ERYTECH (Nasdaq & Euronext : ERYP) et PHERECYDES annoncent leur fusion et leur changement de nom pour …See details»
erytech acquires Pherecydes Pharma - 2023-02-15 - Crunchbase
Feb 15, 2023 Pherecydes Pharma Pherecydes Pharma Operator of an innovative biotechnologies company created to develop personalized phage therapy. Acquiring …See details»
ERYTECH Pharma S.A. completed the acquisition of Pherecydes …
Jun 22, 2023 Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat …See details»
PHERECYDES PHARMA Management Team | Org Chart
PHERECYDES PHARMA employs 36 employees. The PHERECYDES PHARMA management team includes Thibaut du Fayet (Chief Executive Officer), Pascal Birman (Chief Medical …See details»
ERYTECH and PHERECYDES announce merger and name change …
Jun 26, 2023 PHAXIAM Eric Soyer COO & CFO +33 4 78 74 44 38 [email protected]: NewCap Mathilde Bohin / Louis-Victor Delouvrier Relations investisseurs Nicolas MerigeauSee details»
The General Assembly of Pherecydes Pharma Approves the …
May 23, 2022 Pherecydes Pharma (FR0011651694 - ALPHE, éligible PEA-PME) (Paris:ALPHE), a biotech company specializing in precision phage therapy for the treatment of …See details»
Pherecydes Pharma - Contacts, Employees, Board Members
Pherecydes Pharma Operator of an innovative biotechnologies company created to develop personalized phage therapy.See details»
Pherecydes Pharma obtains ANSM approval for its PhagoDAIR …
Jan 3, 2022 Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that it has …See details»